Overview

Low Dose Vasopressin in Traumatic Shock

Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Treatments:
Arginine Vasopressin
Vasopressins